World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02910934
Date of registration: 19/09/2016
Prospective Registration: Yes
Primary sponsor: PATH
Public title: Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique COST
Scientific title: Cost-effectiveness Evaluation of Vector Control Strategies in Mozambique
Date of first enrolment: January 10, 2017
Target sample size: 3915
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02910934
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Health Services Research. Masking: Single (Outcomes Assessor).  
Phase:  N/A
Countries of recruitment
Mozambique United States
Contacts
Name:     Molly Robertson, MA, MPH
Address: 
Telephone:
Email:
Affiliation:  PATH
Name:     Carlos Chaccour, MD, MSc, PhD
Address: 
Telephone:
Email:
Affiliation:  Barcelona Institute for Global Health
Name:     Abuchama Saifodine, PhD
Address: 
Telephone:
Email:
Affiliation:  US Presidents Malaria Initiative, USAID
Name:     Francisco Saute, Md, MSc, PhD
Address: 
Telephone:
Email:
Affiliation:  Centro de Investigacoes de Manhica
Name:     Rose Zulliger, PhD
Address: 
Telephone:
Email:
Affiliation:  US Presidents Malaria Initiative, Centers for Disease Control and Prevention
Key inclusion & exclusion criteria

Inclusion Criteria:

- all consenting adults, assenting minors (12-18) and caregivers of children under 12

Exclusion Criteria:

- all infants 0-6 months of age



Age minimum: 6 Months
Age maximum: N/A
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Intervention(s)
Other: Actellic CS
Primary Outcome(s)
Cost per case averted in children five years of age and under at health facility level by adding Actellic-IRS [Time Frame: 24 months]
Secondary Outcome(s)
Cost per malaria case averted in children five years of age and under at the community [Time Frame: 24months]
Entomological Indicators [Time Frame: 24 months]
Parasite prevalence [Time Frame: 12 months]
Health Behavior [Time Frame: 24 months]
Secondary ID(s)
946238-1 (EOM)
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ministry of Health, Mozambique
Centro de Investigacao em Saude de Manhica
Abt Associates
Centers for Disease Control and Prevention
United States Agency for International Development (USAID)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history